$4.67 Billion is the total value of HHLR ADVISORS, LTD.'s 64 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CIH | Exit | CHINA INDEX HLDGS LTDspnsrd ads a | $0 | – | -300,000 | -100.0% | -0.01% | – |
| SFUN | Exit | FANG HLDGS LTDadr new | $0 | – | -327,720 | -100.0% | -0.02% | – |
| Exit | CHINA JO-JO DRUGSTORES INC | $0 | – | -4,840,000 | -100.0% | -0.03% | – | |
| Exit | TSCAN THERAPEUTICS INC | $0 | – | -669,513 | -100.0% | -0.04% | – | |
| MREO | Exit | MEREO BIOPHARMA GROUP PLCads | $0 | – | -2,976,121 | -100.0% | -0.07% | – |
| FUTU | Exit | FUTU HLDGS LTDspon ads cl a | $0 | – | -130,000 | -100.0% | -0.09% | – |
| ZTO | Exit | ZTO EXPRESS CAYMAN INCsponsored ads a | $0 | – | -200,000 | -100.0% | -0.10% | – |
| Exit | HIPPO HLDGS INC | $0 | – | -2,771,691 | -100.0% | -0.12% | – | |
| Exit | TANGO THERAPEUTICS INC | $0 | – | -882,088 | -100.0% | -0.14% | – | |
| TIL | Exit | INSTIL BIO INC | $0 | – | -2,385,457 | -100.0% | -0.54% | – |
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -120,000 | -100.0% | -0.79% | – |
| LI | Exit | LI AUTO INCsponsored ads | $0 | – | -2,496,550 | -100.0% | -1.34% | – |
| DIDI | Exit | DIDI GLOBAL INCsponsored ads | $0 | – | -36,834,320 | -100.0% | -1.92% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BEIGENE LTD | 20 | Q3 2023 | 26.0% |
| JD.COM INC | 20 | Q3 2023 | 13.1% |
| IQIYI INC | 20 | Q3 2023 | 12.3% |
| MONDELEZ INTL INC | 20 | Q3 2023 | 5.9% |
| KINIKSA PHARMACEUTICALS LTD | 20 | Q3 2023 | 1.6% |
| SOHU COM LTD | 20 | Q3 2023 | 0.6% |
| PINDUODUO INC | 19 | Q3 2023 | 16.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 2.3% |
| BRIDGEBIO PHARMA INC | 18 | Q3 2023 | 3.4% |
| MELCO RESORTS AND ENTMT LTD | 18 | Q1 2023 | 2.8% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
| BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
| Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
| On Holding AG | February 14, 2023 | 5,468,504 | 1.9% |
| Root, Inc. | February 14, 2023 | 138,977 | 1.5% |
| Yatsen Holding Ltd | February 14, 2023 | 300,560,602 | 19.1% |
| iQIYI, Inc. | July 11, 2022 | 149,075,912 | 5.0% |
| Apellis Pharmaceuticals, Inc. | February 14, 2022 | ? | ? |
| Beam Therapeutics Inc. | February 14, 2022 | ? | ? |
| Futu Holdings Ltd | February 14, 2022 | 2 | - |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-02-01 |
| 13F-HR | 2023-11-14 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.